Torrent Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	7,050	5,735	8,351	5,085	3,984	5,726
Short-Term Investments	890	22.8	279	581.6	5.9	264.2
Trading Asset Securities	-	1,122	1,410	1,561	1,840	1,390
Cash & Short-Term Investments	7,940	6,880	10,040	7,228	5,830	7,380
Cash Growth	-35.71%	-31.48%	38.91%	23.98%	-21.01%	11.43%
Accounts Receivable	21,850	18,665	18,443	19,438	16,325	15,234
Other Receivables	-	3,773	3,390	2,844	2,786	3,618
Receivables	21,900	22,480	21,863	22,300	19,137	18,883
Inventory	24,670	25,413	22,791	22,296	24,623	26,812
Prepaid Expenses	-	631.1	589.5	666.9	514.6	548
Restricted Cash	-	49.3	38.6	48	44.4	45.4
Other Current Assets	7,410	773.4	793	753.3	2,798	1,564
Total Current Assets	61,920	56,226	56,115	53,292	52,947	55,232
Property, Plant & Equipment	39,460	38,229	35,778	34,598	32,469	36,272
Long-Term Investments	440	445.7	332.9	711.1	679.2	681.2
Goodwill	3,400	3,389	3,380	3,375	2,595	3,412
Other Intangible Assets	40,430	42,633	45,828	50,895	35,461	39,855
Long-Term Deferred Tax Assets	6,530	5,942	5,551	5,437	4,937	4,217
Other Long-Term Assets	2,930	3,000	3,596	1,785	1,894	1,056
Total Assets	155,150	149,897	150,606	150,119	130,998	140,747
Accounts Payable	16,750	18,200	20,893	16,788	16,744	20,668
Accrued Expenses	-	4,174	3,784	3,690	3,111	3,324
Short-Term Debt	-	12,973	16,551	18,113	9,620	7,590
Current Portion of Long-Term Debt	15,450	5,844	6,959	10,360	9,718	11,800
Current Portion of Leases	340	303.7	200.6	183.3	147.3	264.7
Current Income Taxes Payable	1,300	955.7	1,679	313.1	414.8	539.9
Current Unearned Revenue	-	24.4	50	18.3	114.8	109.2
Other Current Liabilities	10,510	4,698	4,134	5,007	4,280	4,621
Total Current Liabilities	44,350	47,172	54,253	54,473	44,151	48,916
Long-Term Debt	10,450	11,918	16,038	24,962	21,232	29,411
Long-Term Leases	1,980	1,459	644.6	529.3	368.2	222
Long-Term Unearned Revenue	-	4.6	9.6	14.6	19.6	33
Pension & Post-Retirement Benefits	-	813.2	836	788.1	897.5	1,031
Long-Term Deferred Tax Liabilities	7,850	8,287	6,561	4,019	1,936	-
Other Long-Term Liabilities	6,030	4,338	3,703	3,351	2,865	2,762
Total Liabilities	70,660	73,991	82,044	88,138	71,469	82,375
Common Stock	1,690	1,692	1,692	1,692	846.2	846.2
Additional Paid-In Capital	-	-	-	-	43.4	43.4
Retained Earnings	-	76,307	67,908	61,159	57,739	55,905
Comprehensive Income & Other	82,800	-2,092	-1,039	-870.5	900.6	1,577
Total Common Equity	84,490	75,907	68,562	61,981	59,530	58,372
Shareholders' Equity	84,490	75,907	68,562	61,981	59,530	58,372
Total Liabilities & Equity	155,150	149,897	150,606	150,119	130,998	140,747
Total Debt	28,220	32,496	40,394	54,148	41,086	49,287
Net Cash (Debt)	-20,280	-25,616	-30,354	-46,921	-35,257	-41,907
Net Cash Per Share	-59.92	-75.69	-89.69	-138.64	-104.17	-123.82
Filing Date Shares Outstanding	338.68	338.45	338.45	338.45	338.45	338.45
Total Common Shares Outstanding	338.68	338.45	338.45	338.45	338.45	338.45
Working Capital	17,570	9,054	1,862	-1,181	8,796	6,316
Book Value Per Share	249.47	224.28	202.58	183.13	175.89	172.47
Tangible Book Value	40,660	29,886	19,353	7,711	21,474	15,104
Tangible Book Value Per Share	120.05	88.30	57.18	22.78	63.45	44.63
Land	-	6,808	6,804	6,625	6,953	8,210
Buildings	-	15,785	14,910	11,343	11,698	10,149
Machinery	-	30,951	29,168	25,819	25,792	23,298
Construction In Progress	-	3,673	2,808	6,882	5,443	7,439

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.